Gulgul K. Kairanbayeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gulgul K. Kairanbayeva has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Marina K. Balabekova
Department of Pathological Physiology named after Professor A.N. Nurmukhambetov, Asfendiyarov Kazakh National Medical University, 94 Tole-bi St., Almaty 050000, Kazakhstan
6 shared publications - Tulegen M. Seilkhanov
Laboratory of Engineering Profile NMR Spectroscopy, Sh. Ualikhanov Kokshetau University, 76 Abai St., Kokshetau 020000, Kazakhstan
4 shared publications - Valentina Yu
Laboratory of Synthetic and Natural Medicinal Compounds Chemistry, A.B. Bekturov Institute of Chemical Sciences, 106 Sh. Ualikhanov St., Almaty 050010, Kazakhstan
4 shared publications - Meruyert B. Mussilim
Department of Pathological Physiology named after Professor A.N. Nurmukhambetov, Asfendiyarov Kazakh National Medical University, 94 Tole-bi St., Almaty 050000, Kazakhstan
3 shared publications - Tolganay Ye. Zharkynbek
Laboratory of Synthetic and Natural Medicinal Compounds Chemistry, A.B. Bekturov Institute of Chemical Sciences, 106 Sh. Ualikhanov St., Almaty 050010, Kazakhstan
3 shared publications - Aliya N. Tokusheva
Department of Pathological Physiology, Asfendiyarov Kazakh National Medical University, 94 Tole-bi St., Almaty 050000, Kazakhstan
2 shared publications
Latest Publications
- Open Access
Comparative Evaluation of the Early Immunological Effects of a Novel Piperidine α-Hydroxyphosphonate and a Phosphorodiamidate Morpholino Oligomer in an Imiquimod-Induced Psoriasis Model
Psoriasis is a chronic immune-mediated inflammatory disease associated with dysregulation of T-cell responses and cytokine signaling. The aim of this study was to synthesize and structurally characterize a piperidine α-hydroxyphosphonate (OPP) and to comparatively evaluate the effects of OPP and the vivo-phosphorodiamidate morpholino oligomer (vPMO) in a preclinical model of imiquimod-induced psoriasis. OPP was synthesized by hydrophosphorylation of 1-(3-isopropoxypropyl)piperidin-4-one with dimethyl phosphite; its structure was confirmed by IR, NMR spectroscopy, and elemental analysis. Psoriasis was induced in rats by topical application of imiquimod (IMQ). The animals were randomly allocated into six groups: control (C), experimental psoriasis (Ps), vehicle-treated (Ps/V), glucocorticosteroid-treated (Ps/GCS), piperidine α-hydroxyphosphonate-treated (Ps/OPP), and vivo-phosphorodiamidate morpholino oligomer-treated (Ps/vPMO) groups. Clinical manifestations were assessed on Days 3, 5, and 7 using a modified Psoriasis Area and Severity Index (PASI). During the 7-day observation period, body weight and the modified Psoriasis Area and Severity Index (PASI) score were assessed on Days 3, 5, and 7. Histopathological changes were evaluated using hematoxylin and eosin (H&E) staining. On day 7, CD3+CD45R−, CD4+CD8−, and CD4+CD25+ T-cell subpopulations were determined by flow cytometry, while serum concentrations of IL-6, TNF-α, IL-10, TGF-β1, IL-17A, and IL-22 were measured using an enzyme-linked immunosorbent assay (ELISA). IMQ administration resulted in the progressive development of psoriasiform skin lesions characterized by hyperkeratosis, acanthosis, inflammatory infiltration of the dermis, body weight loss, decreased numbers of CD3+CD45R− and CD4+CD8− cells, increased levels of IL-6, IL-17A, and IL-22, and reduced IL-10 levels. OPP treatment was associated with a reduction in the total PASI score and the severity of scaling, as well as decreased serum concentrations of IL-6, IL-17A, and IL-22 and an increased IL-10 concentration. In addition, OPP increased the number of CD4+CD8− cells compared with the psoriasis group, whereas the number of CD4+CD25+ cells remained below the control level. In contrast, vPMO treatment exhibited a distinct response profile characterized by increased numbers of CD3+CD45R− and CD4+CD8− cells, decreased IL-17A and IL-22 levels, increased IL-10 levels, and a particularly pronounced increase in TGF-β1 while producing less pronounced changes in certain cutaneous manifestations. Overall, OPP was characterized by a more consistent pattern of clinical, histopathological, and immunological changes, whereas vPMO treatment predominantly resulted in more pronounced alterations in systemic immunological parameters. These findings indicate distinct patterns of biological effects of OPP and vPMO in the IMQ-induced psoriasiform skin lesion model and support further preclinical investigation of these compounds. However, the observed changes do not allow definitive conclusions to be drawn regarding the underlying molecular mechanisms or the involvement of specific cellular pathways and should be interpreted in light of the limited observation period, the restricted panel of cellular markers examined, the absence of certain experimental controls, and the lack of pharmacokinetic data.
Open AccessComparative Evaluation of the Early Immunological Effects of a Novel Piperidine α-Hydroxyphosphonate and a Phosphorodiamidate Morpholino Oligomer in an Imiquimod-Induced Psoriasis Model
Psoriasis is a chronic immune-mediated inflammatory disease associated with dysregulation of T-cell responses and cytokine signaling. The aim of this study was to synthesize and structurally characterize a piperidine α-hydroxyphosphonate (OPP) and to comparatively evaluate the effects of OPP and the vivo-phosphorodiamidate morpholino oligomer (vPMO) in a preclinical model of imiquimod-induced psoriasis. OPP was synthesized by hydrophosphorylation of 1-(3-isopropoxypropyl)piperidin-4-one with dimethyl phosphite; its structure was confirmed by IR, NMR spectroscopy, and elemental analysis. Psoriasis was induced in rats by topical application of imiquimod (IMQ). The animals were randomly allocated into six groups: control (C), experimental psoriasis (Ps), vehicle-treated (Ps/V), glucocorticosteroid-treated (Ps/GCS), piperidine α-hydroxyphosphonate-treated (Ps/OPP), and vivo-phosphorodiamidate morpholino oligomer-treated (Ps/vPMO) groups. Clinical manifestations were assessed on Days 3, 5, and 7 using a modified Psoriasis Area and Severity Index (PASI). During the 7-day observation period, body weight and the modified Psoriasis Area and Severity Index (PASI) score were assessed on Days 3, 5, and 7. Histopathological changes were evaluated using hematoxylin and eosin (H&E) staining. On day 7, CD3+CD45R−, CD4+CD8−, and CD4+CD25+ T-cell subpopulations were determined by flow cytometry, while serum concentrations of IL-6, TNF-α, IL-10, TGF-β1, IL-17A, and IL-22 were measured using an enzyme-linked immunosorbent assay (ELISA). IMQ administration resulted in the progressive development of psoriasiform skin lesions characterized by hyperkeratosis, acanthosis, inflammatory infiltration of the dermis, body weight loss, decreased numbers of CD3+CD45R− and CD4+CD8− cells, increased levels of IL-6, IL-17A, and IL-22, and reduced IL-10 levels. OPP treatment was associated with a reduction in the total PASI score and the severity of scaling, as well as decreased serum concentrations of IL-6, IL-17A, and IL-22 and an increased IL-10 concentration. In addition, OPP increased the number of CD4+CD8− cells compared with the psoriasis group, whereas the number of CD4+CD25+ cells remained below the control level. In contrast, vPMO treatment exhibited a distinct response profile characterized by increased numbers of CD3+CD45R− and CD4+CD8− cells, decreased IL-17A and IL-22 levels, increased IL-10 levels, and a particularly pronounced increase in TGF-β1 while producing less pronounced changes in certain cutaneous manifestations. Overall, OPP was characterized by a more consistent pattern of clinical, histopathological, and immunological changes, whereas vPMO treatment predominantly resulted in more pronounced alterations in systemic immunological parameters. These findings indicate distinct patterns of biological effects of OPP and vPMO in the IMQ-induced psoriasiform skin lesion model and support further preclinical investigation of these compounds. However, the observed changes do not allow definitive conclusions to be drawn regarding the underlying molecular mechanisms or the involvement of specific cellular pathways and should be interpreted in light of the limited observation period, the restricted panel of cellular markers examined, the absence of certain experimental controls, and the lack of pharmacokinetic data.
- Open Access
- 1 January 2026
- Published by Non-state educational institution "Kazakh-Russian Medical University" in Actual Problems of Theoretical and Clinical Medicine
- Vol. 51 (1)
MODERN CONCEPTS OF THE IMMUNOPATHOGENESIS OF PSORIASIS AND THE PROSPECTS OF ANTISENSE THERAPY
Relevance: Psoriasis is a chronic inflammatory disease characterized by its polygenic nature and the leading role of immune mechanisms. It is based on skin and joint damage. Clinically, the disease is characterized by erythematous rashes covered with silver scales. Despite significant progress in elucidating the pathogenesis and the introduction of targeted biological drugs, it has not yet been possible to achieve sustainable, long-term disease control. In this regard, there is a pressing need to develop new therapeutic strategies targeting key links in the pathogenesis. The use of antisense oligonucleotides is considered a promising therapeutic approach. Objective: To analyze modern concepts of the immunopathogenesis of psoriasis and evaluate the therapeutic potential of antisense oligonucleotides. Materials and Methods: A literature search was conducted in the PubMed, Scopus, Web of Science, Google Scholar, ScienceDirect, and the Cochrane Library databases. Articles published from 2010 to September 2025 were selected for inclusion. Inclusion criteria comprised articles published in peer-reviewed journals focusing on the immune pathogenesis of psoriasis, the IL-23/IL-17 and IL-36 signaling axes, and the therapeutic potential of antisense oligonucleotides. Only publications with full-text availability and direct relevance to the research topic were considered for inclusion. Exclusion criteria included articles not directly relevant to the research topic, duplicate publications, conference abstracts, letters to the editor, and studies without full-text availability. Results: Analysis of recent articles in international scientific databases highlights the importance of the IL-23/IL-17 and IL-36 axes in the development of psoriasis. These signaling pathways support chronic inflammation and promote the pathological proliferation of keratinocytes. Moreover, the obtained data indicate that antisense oligonucleotides may represent a promising approach for pathogenetic therapy and can expand the possibilities for targeted treatment of psoriasis. Conclusions: Psoriasis is a chronic immune-inflammatory disease. In its pathogenesis, the IL-23/IL-17 and IL-36 axes play a key role in the regulation of keratinocyte proliferation, leading to sustained inflammatory mechanisms. Antisense oligonucleotides used in its treatment selectively act on key pathogenic links by suppressing the expression of genes responsible for disease initiation. Although the aforementioned method represents one of the promising approaches for targeted intervention at the molecular level in the disease, there is a need for further in-depth investigation of its efficacy and safety before clinical implementation.
- 1 January 2026
- Published by Non-state educational institution "Kazakh-Russian Medical University" in Actual Problems of Theoretical and Clinical Medicine
- Vol. 51 (1)
Open AccessMODERN CONCEPTS OF THE IMMUNOPATHOGENESIS OF PSORIASIS AND THE PROSPECTS OF ANTISENSE THERAPY
Relevance: Psoriasis is a chronic inflammatory disease characterized by its polygenic nature and the leading role of immune mechanisms. It is based on skin and joint damage. Clinically, the disease is characterized by erythematous rashes covered with silver scales. Despite significant progress in elucidating the pathogenesis and the introduction of targeted biological drugs, it has not yet been possible to achieve sustainable, long-term disease control. In this regard, there is a pressing need to develop new therapeutic strategies targeting key links in the pathogenesis. The use of antisense oligonucleotides is considered a promising therapeutic approach. Objective: To analyze modern concepts of the immunopathogenesis of psoriasis and evaluate the therapeutic potential of antisense oligonucleotides. Materials and Methods: A literature search was conducted in the PubMed, Scopus, Web of Science, Google Scholar, ScienceDirect, and the Cochrane Library databases. Articles published from 2010 to September 2025 were selected for inclusion. Inclusion criteria comprised articles published in peer-reviewed journals focusing on the immune pathogenesis of psoriasis, the IL-23/IL-17 and IL-36 signaling axes, and the therapeutic potential of antisense oligonucleotides. Only publications with full-text availability and direct relevance to the research topic were considered for inclusion. Exclusion criteria included articles not directly relevant to the research topic, duplicate publications, conference abstracts, letters to the editor, and studies without full-text availability. Results: Analysis of recent articles in international scientific databases highlights the importance of the IL-23/IL-17 and IL-36 axes in the development of psoriasis. These signaling pathways support chronic inflammation and promote the pathological proliferation of keratinocytes. Moreover, the obtained data indicate that antisense oligonucleotides may represent a promising approach for pathogenetic therapy and can expand the possibilities for targeted treatment of psoriasis. Conclusions: Psoriasis is a chronic immune-inflammatory disease. In its pathogenesis, the IL-23/IL-17 and IL-36 axes play a key role in the regulation of keratinocyte proliferation, leading to sustained inflammatory mechanisms. Antisense oligonucleotides used in its treatment selectively act on key pathogenic links by suppressing the expression of genes responsible for disease initiation. Although the aforementioned method represents one of the promising approaches for targeted intervention at the molecular level in the disease, there is a need for further in-depth investigation of its efficacy and safety before clinical implementation.
- Open Access
- 9 December 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (12) , 3017
Immunomodulatory Effects of a New Ethynylpiperidine Derivative: Enhancement of CD4+FoxP3+ Regulatory T Cells in Experimental Acute Lung Injury
Background/Objectives: Acute pneumonia remains one of the leading causes of mortality worldwide. The pathogenesis of the disease is determined by the nature of the host immune response. The balance between effector and regulatory T cells (Treg) is critical, as it determines the severity of inflammation and the regenerative capacity of lung tissue. The development of new approaches to modulate the immune response using promising synthetic compounds opens up the possibility of targeted cytokine balance restoration of cytokine balance and Tregs functions This study investigated the effects of the newly synthesized complex of 1-(2-Ethoxypropyl)-4-(pent-1-yn-1-yl)piperidin-4-yl Propionate with β-Cyclodextrin (MXF-22), on the populations of CD4+, CD4+CD25+ and CD4+FoxP3+ T cells in an oleic acid-induced acute lung injury rat model. Methods: Quantitative analysis of CD4+, CD4+CD25+, and CD4+FoxP3+ T cell subsets and serum IL-4 and TGF-β levels were determined by flow cytometry and ELISA assays, respectively. Results: The study revealed a significant decrease in the number of CD4+ T cells and their regulatory subsets (CD4+CD25+, CD4+FoxP3+) during acute pneumonia. Oral administration of MXF-22 contributed to a pronounced recovery of these parameters, accompanied by increased levels of IL-4 and TGF-β, which indicated the activation of anti-inflammatory and reparative processes. Conclusions: MXF-22 showed a pronounced immunomodulatory effect contributing to the restoration of the function of CD4+ FoxP3+ T regs in acute pneumonia rat model.
- 9 December 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (12) , 3017
Open AccessImmunomodulatory Effects of a New Ethynylpiperidine Derivative: Enhancement of CD4+FoxP3+ Regulatory T Cells in Experimental Acute Lung Injury
Background/Objectives: Acute pneumonia remains one of the leading causes of mortality worldwide. The pathogenesis of the disease is determined by the nature of the host immune response. The balance between effector and regulatory T cells (Treg) is critical, as it determines the severity of inflammation and the regenerative capacity of lung tissue. The development of new approaches to modulate the immune response using promising synthetic compounds opens up the possibility of targeted cytokine balance restoration of cytokine balance and Tregs functions This study investigated the effects of the newly synthesized complex of 1-(2-Ethoxypropyl)-4-(pent-1-yn-1-yl)piperidin-4-yl Propionate with β-Cyclodextrin (MXF-22), on the populations of CD4+, CD4+CD25+ and CD4+FoxP3+ T cells in an oleic acid-induced acute lung injury rat model. Methods: Quantitative analysis of CD4+, CD4+CD25+, and CD4+FoxP3+ T cell subsets and serum IL-4 and TGF-β levels were determined by flow cytometry and ELISA assays, respectively. Results: The study revealed a significant decrease in the number of CD4+ T cells and their regulatory subsets (CD4+CD25+, CD4+FoxP3+) during acute pneumonia. Oral administration of MXF-22 contributed to a pronounced recovery of these parameters, accompanied by increased levels of IL-4 and TGF-β, which indicated the activation of anti-inflammatory and reparative processes. Conclusions: MXF-22 showed a pronounced immunomodulatory effect contributing to the restoration of the function of CD4+ FoxP3+ T regs in acute pneumonia rat model.
- Open Access
- 1 January 2025
- Published by International Society of Communication and Development Between Universities (ISCDBU) in Journal of Medicinal and Chemical Sciences
- Vol. 8 (1) , 31-42
Regenerative potential of Houttuynia cordata Chameleon in an acute pneumonia model
This study investigates the potential of natural compounds, particularly from medicinal plants, in the treatment of inflammatory processes. Compared to synthetic drugs, natural agents often provide mild immunomodulatory effects, exhibit low toxicity, and support the immune, nervous, and endocrine systems through complex biologically active substances. These properties make plant-derived compounds an essential focus for current research, especially in the context of inflammatory diseases and immune modulation. Among the diverse flora of Kazakhstan, Houttuynia cordata ‘Chameleon’ shows promise as an anti-inflammatory, antiviral, antioxidant, and antitumor agent. Previous studies, including research by Hong Kong University of Chinese Medicine, demonstrate the immunomodulatory properties of Houttuynia cordata, which may aid in preventing viral infections, such as those caused by SARS-CoV-2. The plant's bioactive compounds appear to support cell-mediated immunity, underscoring the potential of natural compounds in pharmacology and related fields such as cell biology, immunology, and pathophysiology. This study aims to further examine these mechanisms, highlighting the medicinal potential of Kazakhstan’s unique flora.
- 1 January 2025
- Published by International Society of Communication and Development Between Universities (ISCDBU) in Journal of Medicinal and Chemical Sciences
- Vol. 8 (1) , 31-42
Open AccessRegenerative potential of Houttuynia cordata Chameleon in an acute pneumonia model
This study investigates the potential of natural compounds, particularly from medicinal plants, in the treatment of inflammatory processes. Compared to synthetic drugs, natural agents often provide mild immunomodulatory effects, exhibit low toxicity, and support the immune, nervous, and endocrine systems through complex biologically active substances. These properties make plant-derived compounds an essential focus for current research, especially in the context of inflammatory diseases and immune modulation. Among the diverse flora of Kazakhstan, Houttuynia cordata ‘Chameleon’ shows promise as an anti-inflammatory, antiviral, antioxidant, and antitumor agent. Previous studies, including research by Hong Kong University of Chinese Medicine, demonstrate the immunomodulatory properties of Houttuynia cordata, which may aid in preventing viral infections, such as those caused by SARS-CoV-2. The plant's bioactive compounds appear to support cell-mediated immunity, underscoring the potential of natural compounds in pharmacology and related fields such as cell biology, immunology, and pathophysiology. This study aims to further examine these mechanisms, highlighting the medicinal potential of Kazakhstan’s unique flora.
- Open Access
- 1 November 2024
- Published by International Society of Communication and Development Between Universities (ISCDBU) in Journal of Medicinal and Chemical Sciences
- Vol. 7 (11) , 1411-1421
Toxic Effects of Heavy Metals on the Immune System and New Approaches to Restoring Homeostasis
Heavy metals such as cadmium and lead have profound effects on the immune system, causing both overstimulation and suppression of immune responses. This dysregulation leads to immune dysfunction and increases the risk of adverse inflammatory outcomes. Disruption of immune regulation can result in chronic inflammation, requiring a detailed understanding to develop effective therapeutic strategies. The aim of the present study was to investigate the effects of cadmium chloride (CdСl2) and lead acetate (Pb(CH3COO)2) on the course of aseptic inflammation (SI), as well as the possibility of immune modulation of the identified disorders. The study was conducted on 4 groups of animals, with 42 outbred male rats weighing 180-220 g (±20 g), kept under standard vivarium conditions on a regular diet. Experimental animals were intoxicated with 2.5 mg/kg doses of Cd and Pb orally for two weeks, after which aseptic inflammation was modeled in the animals. In this work, we investigated the activity of CD4+, CD4+CD25+ (activated T cells), CD4+FoxP3+, CD4+FoxP3+CTLA-4+, CD45R(B220), RT1+ from the CD45+CD45R(B220) + population using flow cytometry; IL-6, TGFβ using enzyme-linked immunosorbent assay (ELISA); and hematological blood analysis. It was found that cadmium and lead salts cause immune system dysfunction, leading to dysregulation of inflammation and increasing the risk of adverse outcomes. Treatment with Complex demonstrated potential in restoring the balance of effector and regulatory lymphocytes. Complex, after 7 days, through activation of IL-6 and TGF-β, restored splenic CD4+ lymphocyte populations, selectively stimulated FoxP3+ expression, but did not affect the suppressive activity of CTLA-4+. Complex also activated innate and adaptive immunity, enhancing the antigen-presenting activity of macrophages and stimulating leukocyte reactions, which is especially important for a favorable outcome of the inflammatory process against the background of heavy metal intoxication.
- 1 November 2024
- Published by International Society of Communication and Development Between Universities (ISCDBU) in Journal of Medicinal and Chemical Sciences
- Vol. 7 (11) , 1411-1421
Open AccessToxic Effects of Heavy Metals on the Immune System and New Approaches to Restoring Homeostasis
Heavy metals such as cadmium and lead have profound effects on the immune system, causing both overstimulation and suppression of immune responses. This dysregulation leads to immune dysfunction and increases the risk of adverse inflammatory outcomes. Disruption of immune regulation can result in chronic inflammation, requiring a detailed understanding to develop effective therapeutic strategies. The aim of the present study was to investigate the effects of cadmium chloride (CdСl2) and lead acetate (Pb(CH3COO)2) on the course of aseptic inflammation (SI), as well as the possibility of immune modulation of the identified disorders. The study was conducted on 4 groups of animals, with 42 outbred male rats weighing 180-220 g (±20 g), kept under standard vivarium conditions on a regular diet. Experimental animals were intoxicated with 2.5 mg/kg doses of Cd and Pb orally for two weeks, after which aseptic inflammation was modeled in the animals. In this work, we investigated the activity of CD4+, CD4+CD25+ (activated T cells), CD4+FoxP3+, CD4+FoxP3+CTLA-4+, CD45R(B220), RT1+ from the CD45+CD45R(B220) + population using flow cytometry; IL-6, TGFβ using enzyme-linked immunosorbent assay (ELISA); and hematological blood analysis. It was found that cadmium and lead salts cause immune system dysfunction, leading to dysregulation of inflammation and increasing the risk of adverse outcomes. Treatment with Complex demonstrated potential in restoring the balance of effector and regulatory lymphocytes. Complex, after 7 days, through activation of IL-6 and TGF-β, restored splenic CD4+ lymphocyte populations, selectively stimulated FoxP3+ expression, but did not affect the suppressive activity of CTLA-4+. Complex also activated innate and adaptive immunity, enhancing the antigen-presenting activity of macrophages and stimulating leukocyte reactions, which is especially important for a favorable outcome of the inflammatory process against the background of heavy metal intoxication.
- Open Access
Enhancing Aseptic Inflammation Resolution with 1-(2-Ethoxyethyl)-4-(pent-1-yn-1-yl)piperidin-4-yl Propionate: A Novel β-Cyclodextrin Complex as a Therapeutic Agent
The synthesized compound, 1-(2-ethoxyethyl)-4-(pent-1-yn-1-yl)piperidin-4-yl propionate (EPPP), and its 1:1 complex with β-cyclodextrin (EPPPβCD) have been characterized for the first time through a comprehensive suite of analytical methods. This study explores the therapeutic potential of EPPPβCD in modulating immune responses and accelerating the resolution of septic inflammation induced by chromium and vanadium ions in outbred male rats. The research highlights the significant impact of EPPPβCD on the dynamics of regulatory T lymphocytes (Tregs), notably causing a reduction in the CD4+CD25+ fractions at the onset of inflammation. This effect is attributed to the inhibition of Treg proliferation, which is crucial in hastening the resolution of inflammation. These findings underscore the potential of EPPPβCD as a promising therapeutic agent in controlling and mitigating inflammation mediated by heavy metal exposure, thereby offering a new avenue for the development of anti-inflammatory treatments.
Open AccessEnhancing Aseptic Inflammation Resolution with 1-(2-Ethoxyethyl)-4-(pent-1-yn-1-yl)piperidin-4-yl Propionate: A Novel β-Cyclodextrin Complex as a Therapeutic Agent
The synthesized compound, 1-(2-ethoxyethyl)-4-(pent-1-yn-1-yl)piperidin-4-yl propionate (EPPP), and its 1:1 complex with β-cyclodextrin (EPPPβCD) have been characterized for the first time through a comprehensive suite of analytical methods. This study explores the therapeutic potential of EPPPβCD in modulating immune responses and accelerating the resolution of septic inflammation induced by chromium and vanadium ions in outbred male rats. The research highlights the significant impact of EPPPβCD on the dynamics of regulatory T lymphocytes (Tregs), notably causing a reduction in the CD4+CD25+ fractions at the onset of inflammation. This effect is attributed to the inhibition of Treg proliferation, which is crucial in hastening the resolution of inflammation. These findings underscore the potential of EPPPβCD as a promising therapeutic agent in controlling and mitigating inflammation mediated by heavy metal exposure, thereby offering a new avenue for the development of anti-inflammatory treatments.
- Open Access
Naphthaleneoxypropargyl-Containing Piperazine as a Regulator of Effector Immune Cell Populations upon an Aseptic Inflammation
This study investigated the effects of aseptic inflammation and heavy metal exposure on immune responses, as well as the potential immunomodulatory properties of the newly synthesized 1-[1-(2,5-dimethoxyphenyl)-4-(naphthalene-1-yloxy)but-2-ynyl]-4-methylpiperazine complexed with β-cyclodextrin (β-CD). Aseptic inflammation was induced by a subcutaneous injection of turpentine in rats, while heavy metal exposure was achieved through a daily administration of cadmium chloride and lead acetate. The levels of immune cell populations, including cytotoxic T lymphocytes (CTL), monocytes, and granulocytes, were assessed in the spleen. The results showed that aseptic inflammation led to decreased levels of CTL, monocytes, and granulocytes on the 14th day, indicating an inflammatory response accompanied by a migration of effector cells to the inflamed tissues. The exposure to cadmium chloride and lead acetate resulted in systemic immunotoxic effects, with reduced levels of B cells, CD4+ Th cells, monocytes, and granulocytes in the spleen. Notably, piperazine complexed with β-CD (the complex) exhibited significant stimulatory effects on CD4+, CD8+, and myeloid cell populations during aseptic inflammation, even in the presence of heavy metal exposure. These findings suggest the potential immunomodulatory properties of the complex in the context of aseptic inflammation and heavy metal exposure.
Open AccessNaphthaleneoxypropargyl-Containing Piperazine as a Regulator of Effector Immune Cell Populations upon an Aseptic Inflammation
This study investigated the effects of aseptic inflammation and heavy metal exposure on immune responses, as well as the potential immunomodulatory properties of the newly synthesized 1-[1-(2,5-dimethoxyphenyl)-4-(naphthalene-1-yloxy)but-2-ynyl]-4-methylpiperazine complexed with β-cyclodextrin (β-CD). Aseptic inflammation was induced by a subcutaneous injection of turpentine in rats, while heavy metal exposure was achieved through a daily administration of cadmium chloride and lead acetate. The levels of immune cell populations, including cytotoxic T lymphocytes (CTL), monocytes, and granulocytes, were assessed in the spleen. The results showed that aseptic inflammation led to decreased levels of CTL, monocytes, and granulocytes on the 14th day, indicating an inflammatory response accompanied by a migration of effector cells to the inflamed tissues. The exposure to cadmium chloride and lead acetate resulted in systemic immunotoxic effects, with reduced levels of B cells, CD4+ Th cells, monocytes, and granulocytes in the spleen. Notably, piperazine complexed with β-CD (the complex) exhibited significant stimulatory effects on CD4+, CD8+, and myeloid cell populations during aseptic inflammation, even in the presence of heavy metal exposure. These findings suggest the potential immunomodulatory properties of the complex in the context of aseptic inflammation and heavy metal exposure.